Your browser doesn't support javascript.
loading
Mostrar: 20 | 50 | 100
Resultados 1 - 19 de 19
Filtrar
1.
Biol Pharm Bull ; 47(5): 1000-1007, 2024.
Artigo em Inglês | MEDLINE | ID: mdl-38777758

RESUMO

Previously, insulin resistance and hepatic oxidative stress with increased expressions of glutathione peroxidase (GPx) 1 and selenoprotein P (SelP) were induced in NSY mice, a diabetic mouse model, by administrating a high fat diet (HFD) and seleno-L-methionine (SeMet) for 12 weeks. In this study we developed an analysis method for serum selenoproteins using LC-tandem mass spectrometry (LC-MS/MS) and investigated the effects of supplementary selenium on serum concentrations of selenoproteins as well as protein expression in skeletal muscle as a major insulin target tissue under the same experimental condition. The glucose area under the curves for oral glucose tolerance and insulin tolerance tests indicated that the HFD induced insulin resistance, whereas the treatment of SeMet + HFD showed insignificant promotion compared with the HFD-induced insulin resistance. Although the expressions of GPx1 in gastrocnemius and soleus were not significantly induced by supplementary SeMet nor HFD administration, the expressions of SelP in both skeletal muscles were significantly induced by the treatment of SeMet + HFD. There were also significant increases in serum concentrations of SelP by supplementary SeMet + HFD administration, whereas GPx3 was augmented by supplementary SeMet only. These results indicated that the HFD intake under the sufficient selenium status augmented the blood secretion of SelP, which may participate in the reduction of insulin sensitivity in skeletal muscles as well as liver or adipose tissues, and it is a better indicator of deterioration than GPx3 as it is a major selenoprotein in serum.


Assuntos
Dieta Hiperlipídica , Suplementos Nutricionais , Glutationa Peroxidase , Resistência à Insulina , Músculo Esquelético , Selênio , Selenoproteínas , Animais , Músculo Esquelético/metabolismo , Músculo Esquelético/efeitos dos fármacos , Masculino , Selenoproteínas/metabolismo , Dieta Hiperlipídica/efeitos adversos , Camundongos , Glutationa Peroxidase/metabolismo , Glutationa Peroxidase/sangue , Selênio/sangue , Selênio/administração & dosagem , Glutationa Peroxidase GPX1 , Selenometionina/farmacologia , Selenometionina/administração & dosagem , Selenoproteína P/sangue , Selenoproteína P/metabolismo , Modelos Animais de Doenças , Glicemia/metabolismo , Insulina/sangue , Espectrometria de Massas em Tandem
2.
Biol Pharm Bull ; 44(6): 838-843, 2021.
Artigo em Inglês | MEDLINE | ID: mdl-34078816

RESUMO

The excessive ingestion of oxidized dietary oils may exacerbate some allergic diseases. We previously reported that oxidized olive oil exacerbates active cutaneous anaphylaxis (ACA), one of the immediate allergic reactions. This study was conducted to clarify the effects of oxidized olive oil on the T cell response during ACA. BALB/c female mice were orally administered naturally oxidized olive oil once every 2 d for 2 weeks after ovalbumin (OVA)/aluminum hydroxide gel sensitization, after which ACA was elicited by intracutaneous administration of OVA into the ear auricles. Compared with fresh olive oil, oxidized olive oil administration increased the antigen-specific immunoglobulin E (IgE) antibody titer 2 weeks after OVA-sensitization and vascular hyperpermeability increased due to ACA. In the oxidized olive oil-administered mice, the mRNA expression levels of T-helper 2 (Th2) cytokines, interleukin (IL)-4, -5, -6, and -10, in the lymph nodes increased, as did the proportion of cluster designation (CD)3+CD4+ cells in the spleen and lymph nodes. In CD3+CD4+ cells, the mRNA expression levels of IL-4 and GATA-binding protein 3 (GATA3), the master regulator of Th2, were higher in the oxidized olive oil-group. Antigen-stimulated specific IL-4 production was promoted in CD3+CD4+ cells of oxidized olive oil-administered mice. This suggests that oxidized olive oil exacerbates ACA by promoting Th2 dominance in immediate allergic diseases.


Assuntos
Anafilaxia/imunologia , Azeite de Oliva , Dermatopatias/imunologia , Anafilaxia/genética , Animais , Proliferação de Células , Células Cultivadas , Técnicas de Cocultura , Citocinas/genética , Citocinas/imunologia , Feminino , Imunoglobulina E/imunologia , Linfonodos/imunologia , Macrófagos Peritoneais/imunologia , Camundongos Endogâmicos BALB C , Oxirredução , Dermatopatias/genética , Baço/citologia , Linfócitos T/imunologia
3.
Biol Pharm Bull ; 42(7): 1179-1184, 2019 Jul 01.
Artigo em Inglês | MEDLINE | ID: mdl-30982787

RESUMO

The effect of seleno-L-methionine (SeMet) on immunoglobulin (Ig) E-mediated allergic responses were investigated using rat basophilic leukemia RBL-2H3 cells. Cells were first treated with or without SeMet, sensitized with anti-dinitrophenyl IgE and stimulated with the antigen dinitrophenyl-human serum albumin, before the measurement of degranulation, calcium mobilization, mRNA expression and protein secretion of interleukin (IL)-4 and tumor necrosis factor (TNF)-α, and phosphorylation of spleen tyrosine kinase (Syk), Akt, and mitogen-activated protein kinases (MAPKs). The antigen-induced ß-hexosaminidase release, a degranulation marker, was significantly inhibited by SeMet treatment. SeMet also significantly suppressed antigen-induced calcium mobilization. Antigen-induced increases in the mRNA expression and protein secretion of IL-4 and TNF-α were both significantly attenuated by SeMet treatment. In addition, SeMet significantly suppressed antigen-induced phosphorylation of Syk, Akt, and MAPKs. These results demonstrate that SeMet suppresses antigen-induced degranulation, and mRNA expression and protein secretion of IL-4 and TNF-α, and inhibits antigen-induced mobilization of calcium and activation of Syk, Akt, and MAPKs. Our study provides valuable information that may be useful in the prevention and treatment of allergic diseases.


Assuntos
Hipersensibilidade/imunologia , Imunoglobulina E/imunologia , Metionina/análogos & derivados , Metionina/farmacologia , Compostos de Selênio/farmacologia , Animais , Cálcio/imunologia , Linhagem Celular Tumoral , Interleucina-4/imunologia , Ratos , Fator de Necrose Tumoral alfa/imunologia , beta-N-Acetil-Hexosaminidases/imunologia
4.
Biol Pharm Bull ; 41(9): 1456-1462, 2018.
Artigo em Inglês | MEDLINE | ID: mdl-30175780

RESUMO

Effects of selenium supplementation on atopic dermatitis (AD) were investigated by administering seleno-L-methionine (SeMet) using a mouse model of AD caused by repeated application of 2,4,6-trinitrochlorobenzene (TNCB). BALB/c mice were sensitized with TNCB to the abdomen on day -7; then, TNCB was applied repeatedly to each ear three times a week from days 0 to 23. SeMet was orally administered to the mice from days 0 to 23. The efficacy of SeMet on AD was assessed by measuring ear thickness, histologic evaluation, serum total immunoglobulin (Ig) E levels, and expression of interleukin (IL)-4 in the ear and superficial parotid lymph node. Ear thickness was remarkably increased by repeated application of TNCB, and SeMet significantly suppressed ear thickness in BALB/c mice. SeMet inhibited epidermal hyperplasia and dense infiltration of inflammatory cells. The number of TNCB-induced mast cells was significantly decreased by SeMet. Serum total IgE levels that increased by the repeated application of TNCB were significantly suppressed by SeMet. Repeated application of TNCB induced expression of IL-4, a T-helper (Th) 2 cytokine, in the ear and superficial parotid lymph node of BALB/c mice and its expression was significantly inhibited by SeMet. These results demonstrated that SeMet supplementation suppresses AD-like skin lesions in BALB/c mice and inhibits the expression of total IgE and IL-4.


Assuntos
Antialérgicos/uso terapêutico , Dermatite Atópica/tratamento farmacológico , Imunoglobulina E/sangue , Interleucina-4/imunologia , Selenometionina/uso terapêutico , Animais , Antialérgicos/farmacologia , Doença Crônica , Dermatite Atópica/sangue , Dermatite Atópica/imunologia , Feminino , Interleucina-4/genética , Fígado/metabolismo , Linfonodos/efeitos dos fármacos , Linfonodos/imunologia , Mastócitos/efeitos dos fármacos , Camundongos Endogâmicos BALB C , Cloreto de Picrila , Selenometionina/farmacologia
5.
Biol Pharm Bull ; 41(1): 80-85, 2018.
Artigo em Inglês | MEDLINE | ID: mdl-29311486

RESUMO

The protective effects of seleno-L-methionine (SeMet) on oxidative stress in pancreatic islets were investigated with a short-term nicotinamide (NA) and streptozotocin (STZ)-induced diabetic mouse model. ICR mice were intraperitoneally injected twice with 100 mg/kg STZ and 120 mg/kg NA at a 1-d interval and were then orally administered 158 µg Se/kg SeMet with free access to a selenium-deficient diet for 5 weeks. Administration of SeMet significantly improved the levels of glycated hemoglobin (HbA1c), non-fasting and oral glucose tolerance-tested (OGTT) blood glucose, plasma adiponectin and hepatic glycogen that deteriorated by NA/STZ treatment. However, supplementary SeMet did not restore non-fasting plasma insulin levels in NA/STZ treatment group and significantly suppressed OGTT plasma insulin levels in the control group. Although SeMet significantly suppressed 8-hydroxy-2'-deoxyguanosine density in pancreatic islets, SeMet did not restore insulin density. The hepatic and pancreatic mRNA levels of glutathione peroxidase 1 (GPX1) increased by NA/STZ treatment or SeMet administration. These results suggest that although a physiological level of SeMet improves glucose tolerance by exhibiting insulin-mimetic activity in a short-term induced diabetic mouse model under insufficient Se status, the suppression of pancreatic oxidative stress with the induction GPX1 by SeMet supplementation is unlikely to restore insulin storage and secretion.


Assuntos
Diabetes Mellitus Experimental/tratamento farmacológico , Diabetes Mellitus Tipo 2/tratamento farmacológico , Ilhotas Pancreáticas/efeitos dos fármacos , Estresse Oxidativo/efeitos dos fármacos , Selênio/deficiência , Selenometionina/farmacologia , Animais , Diabetes Mellitus Experimental/sangue , Diabetes Mellitus Tipo 2/sangue , Teste de Tolerância a Glucose , Hemoglobinas Glicadas/análise , Insulina/sangue , Insulina/metabolismo , Secreção de Insulina , Ilhotas Pancreáticas/metabolismo , Camundongos Endogâmicos ICR , Niacinamida , Selenometionina/uso terapêutico , Estreptozocina , Fatores de Tempo
6.
Biol Pharm Bull ; 41(1): 92-98, 2018.
Artigo em Inglês | MEDLINE | ID: mdl-29311488

RESUMO

The role of supplementary selenium on the induction of insulin resistance and oxidative stress in a diabetic mouse model was investigated in NSY mice on a high fat diet (HFD) and administered seleno-L-methionine (SeMet)-containing water for 12 weeks. Significant increases in oral glucose tolerance-tested (OGTT), insulin tolerance-tested, and non-fasting blood glucose levels were observed in mice on a HFD, as well as the significant increases in OGTT and non-fasting plasma insulin levels. Mice on a HFD had decreased plasma adiponectin levels and increased free fatty acid (FFA) levels. Supplementary SeMet significantly augmented OGTT blood glucose levels in mice on a HFD and plasma FFA levels in mice on a normal diet. The mRNA levels of six selenoproteins were measured, and glutathione peroxidase (GPx) 1 and selenoprotein P (SelP) were selected as candidates that may be associated with insulin resistance or oxidative stress in the liver. Hepatic GPx1 expression was elevated in mice on a HFD and SeMet supplementation, and SelP expression increased in mice on a HFD. Histopathological observations in hepatic tissues showed hypertrophy of parenchymal cells and significant expression of 4-hydroxy-2-nonenal in mice on a HFD, indicating lipid accumulation and oxidative stress induction. Hepatic protein tyrosine phosphatase activity also increased by a HFD. These results suggest that hepatic lipid accumulation in NSY mice on a HFD promoted oxidative stress and hepatic SelP expression, and supplementary SeMet induced hepatic GPx1 expression.


Assuntos
Diabetes Mellitus Experimental/metabolismo , Dieta Hiperlipídica/efeitos adversos , Resistência à Insulina , Estresse Oxidativo/efeitos dos fármacos , Selenometionina/farmacologia , Selenoproteínas/biossíntese , Animais , Biomarcadores/sangue , Glicemia/análise , Diabetes Mellitus Experimental/sangue , Suplementos Nutricionais , Fígado/efeitos dos fármacos , Fígado/metabolismo , Fígado/patologia , Camundongos Endogâmicos , Selênio/metabolismo
7.
Allergol Int ; 64(1): 66-72, 2015 Jan.
Artigo em Inglês | MEDLINE | ID: mdl-25605529

RESUMO

BACKGROUND: The consumption of cooking oils may exacerbate some allergic diseases. In the present study, the effects of naturally oxidized olive oil on immediate- and/or delayed-type allergic reactions were investigated in BALB/c mice. METHODS: Mouse models of 3 types of allergic reactions: contact hypersensitivity (CHS), active cutaneous anaphylaxis (ACA), and DNFB-induced hypersensitivity, were orally administered naturally oxidized olive oil that was obtained by keeping the oil at room temperature for more than 3 years. The effects of ultraviolet ray (UV)-irradiated olive oil and other dietary oils as well as their possible oxidation products on CHS were also investigated. RESULTS: Naturally oxidized olive oil had a high peroxide value (POV) and exacerbated CHS, ACA, and DNFB-induced hypersensitivity in a POV-dependent manner. UV-irradiated olive oil, corn oil, sesame oil and triolein had high POVs, but almost the same acid value (AV) and thiobarbituric acid-reactive substance (TBARS) level as fresh oils. Fresh olive oil and the representative oxidation product with a high AV or TBARS level had no effect on CHS, whereas all UV-irradiated oils and naturally oxidized olive oil exacerbated it. CONCLUSIONS: Oxidized dietary oils that have high POVs exacerbated immediate- and/or delayed-type allergic reactions regardless of the different oil constituents or oxidation processes.


Assuntos
Gorduras Insaturadas na Dieta/imunologia , Hipersensibilidade Tardia/imunologia , Hipersensibilidade Imediata/imunologia , Anafilaxia/imunologia , Animais , Dermatite de Contato/imunologia , Gorduras Insaturadas na Dieta/administração & dosagem , Modelos Animais de Doenças , Relação Dose-Resposta Imunológica , Edema/imunologia , Feminino , Imunização , Imunização Secundária , Imunoglobulina E/sangue , Imunoglobulina E/imunologia , Camundongos , Camundongos Endogâmicos BALB C , Fatores de Tempo
8.
Yakugaku Zasshi ; 134(11): 1199-208, 2014.
Artigo em Japonês | MEDLINE | ID: mdl-25366917

RESUMO

The Faculty of Pharmaceutical Sciences, Setsunan University, offers the Self-improvement and Participatory Career Development Education Program: Internship and Volunteer Training Experience for Pharmacy Students to third-year students. We previously reported that the training experience was effective in cultivating important attributes among students, such as a willingness to learn the aims of pharmacists, an awareness of their own role as healthcare workers, and a desire to reflect on their future careers and lives. A follow-up survey of the participants was carried out three years after the training experience. The questionnaire verified that the training experience affected attendance at subsequent lectures and course determination after graduation. We confirmed the relationship between the participants' degree of satisfaction with the training experience and increased motivation for attending subsequent lectures. Through the training experience, participants discovered future targets and subjects of study. In addition, they became more interested in subsequent classroom lessons and their future. The greater the participants' degree of satisfaction with their training experience, the more interest they took in practical training and future courses. The present study clarified that the training experience was effective in cultivating important attributes such as a willingness to learn and an interest in future courses. Moreover, the training positively affected the course determination after graduation.


Assuntos
Educação em Farmácia , Internato e Residência , Seguimentos , Humanos , Internato e Residência/métodos , Estudantes de Farmácia , Inquéritos e Questionários
9.
Biol Pharm Bull ; 37(11): 1831-7, 2014.
Artigo em Inglês | MEDLINE | ID: mdl-25177040

RESUMO

The aim of the present study was to clarify the mechanism underlying the inhibition of cell proliferation in human lung cancer A549 cells by selenium (Se) compounds. Methylseleninic acid (CH3SeO2H, abbreviated as MSA), a synthetic Se compound, is a direct precursor of active methylselenol (CH3SeH) and is considered to be one of beneficial agents for cancer prevention and therapy. Sodium selenite (Na2SeO3), an inorganic Se form, is utilized in clinical Se supplementation. MSA markedly inhibited the growth of A549 cells at a concentration of 2.5×10(-6) mol/L for 1 d. On Day 1, Na2SeO3 also inhibited A549 cell growth at the concentration of 7.5×10(-6) mol/L. These compounds induced cell cycle arrest at the G1 phase and apoptosis under the inhibitory condition. Reduced glutathione (GSH) is critical to MSA or Na2SeO3 metabolism. The depletion of intracellular GSH suppressed Na2SeO3-induced G1 arrest, but promoted Na2SeO3-induced apoptosis. Therefore, Na2SeO3 appears to have directly induced apoptosis. In contrast, the MSA-induced G1 arrest was ameliorated by a marked decrease in GSH content. Additionally, the depletion of GSH slightly suppressed MSA-induced apoptosis. The difference in inhibitory effects between MSA and Na2SeO3 may be due to this variation in GSH-related metabolism. After exposure of A549 cells to MSA, the GSH content was significantly decreased. These results indicate that because MSA-induced G1 arrest and apoptosis induction are enhanced by GSH, the maintenance of GSH is essential for the effective anticancer action of MSA in A549 cells.


Assuntos
Antineoplásicos/farmacologia , Apoptose/efeitos dos fármacos , Pontos de Checagem da Fase G1 do Ciclo Celular/efeitos dos fármacos , Glutationa/metabolismo , Compostos Organosselênicos/farmacologia , Selenito de Sódio/farmacologia , Linhagem Celular Tumoral , Perfilação da Expressão Gênica , Humanos , Neoplasias Pulmonares/metabolismo
10.
Biol Pharm Bull ; 37(9): 1569-74, 2014.
Artigo em Inglês | MEDLINE | ID: mdl-25177039

RESUMO

The effects of administering the selenocompounds, sodium selenite, methylseleninic acid (MSA), and seleno-L-methionine (SeMet) on glucose tolerance were compared in the nicotinamide (NA) and streptozotocin (STZ)-induced diabetic mouse model. ICR mice were intraperitoneally treated twice with STZ (100 mg/kg) 15 min after an injection of NA (120 mg/kg) at a 1-d interval. Non-fasting blood glucose levels were then monitored weekly while orally administering the selenocompounds at 158 µg Se/kg body weight with free access to a selenium-deficient diet for 5 weeks. The mean body weights of NA/STZ-induced diabetic mice were partly restored by the administration of selenocompounds, while SeMet led to a higher selenium content and glutathione peroxidase 1 activity in the pancreas. Non-fasting and oral glucose tolerance-tested blood glucose levels, which were elevated by NA/STZ, were significantly suppressed by the administration of SeMet. These results suggest that SeMet may improve glucose tolerance in a NA/STZ-induced mild diabetic mouse model by increasing bioavailability in the pancreas.


Assuntos
Diabetes Mellitus Experimental/tratamento farmacológico , Hipoglicemiantes , Compostos Organosselênicos , Selenometionina , Selenito de Sódio , Animais , Disponibilidade Biológica , Glicemia/efeitos dos fármacos , Diabetes Mellitus Experimental/sangue , Diabetes Mellitus Experimental/induzido quimicamente , Diabetes Mellitus Experimental/metabolismo , Teste de Tolerância a Glucose , Glutationa Peroxidase/metabolismo , Hipoglicemiantes/farmacocinética , Hipoglicemiantes/farmacologia , Hipoglicemiantes/uso terapêutico , Fígado/metabolismo , Masculino , Camundongos Endogâmicos ICR , Niacinamida , Compostos Organosselênicos/farmacocinética , Compostos Organosselênicos/farmacologia , Compostos Organosselênicos/uso terapêutico , Pâncreas/metabolismo , Selenometionina/farmacocinética , Selenometionina/farmacologia , Selenometionina/uso terapêutico , Selenito de Sódio/farmacocinética , Selenito de Sódio/farmacologia , Selenito de Sódio/uso terapêutico , Estreptozocina , Glutationa Peroxidase GPX1
11.
Biol Pharm Bull ; 37(8): 1352-8, 2014.
Artigo em Inglês | MEDLINE | ID: mdl-25087957

RESUMO

Although supplementation with the selenocompound, sodium selenite has been shown to stimulate the concanavalin A-induced T-cell mitogenic response, the mechanisms responsible remain unclear. This study was conducted to evaluate the relationships between the induction of apoptosis, formation of tumor necrosis factor (TNF)-alpha and reactive oxygen species (ROS), activation of apoptosis signal-regulating kinase (ASK) 1 and the thioredoxin (Trx) system when mitogenesis was stimulated by selenite. TNF-alpha was dose-dependently released by mouse splenocytes treated with selenite, and apoptosis was induced when TNF-alpha was added at the indicated concentrations. However, supplementation with selenite at low concentrations inhibited the accumulation of ROS with the increased expression of Trx reductase 1 and induction of apoptosis in wild-type splenocytes, and also at high concentrations in Trx-1-transgenic mouse splenocytes. The suppression of apoptosis was accompanied by a decrease in the expression of phospho-ASK1. These results suggest that the stimulation of T-cell mitogenesis by selenite may be partly attributed to the inhibited accumulation of ROS due to a reduced Trx-1/TR1 system, the inactivation of ASK1, and the suppression of apoptosis.


Assuntos
MAP Quinase Quinase Quinase 5/metabolismo , Espécies Reativas de Oxigênio/metabolismo , Ácido Selenioso/farmacologia , Linfócitos T/efeitos dos fármacos , Tiorredoxinas/metabolismo , Animais , Apoptose/efeitos dos fármacos , Proliferação de Células/efeitos dos fármacos , Células Cultivadas , Concanavalina A/farmacologia , Masculino , Camundongos Endogâmicos C57BL , Camundongos Transgênicos , Mitógenos/farmacologia , Baço/citologia , Linfócitos T/citologia , Linfócitos T/metabolismo , Tiorredoxinas/genética , Fator de Necrose Tumoral alfa/metabolismo
12.
Alcohol ; 48(5): 501-8, 2014 Aug.
Artigo em Inglês | MEDLINE | ID: mdl-24953256

RESUMO

Alcohol injures dendritic cells and suppresses cellular immunity, while some evidence indicates that drinking alcohol aggravates allergic asthma. This study investigated the effect of low doses of ethanol in enhancing allergic reactions in the skin of mice. Liquid food containing alcohol was administered to conventional NC/Nga mice to induce alcoholic hepatic steatosis, and spontaneous dermatitis was evaluated. BALB/c mice were administered approximately 1 g/kg body weight of ethanol by gavage, and contact hypersensitivity (CHS) or active cutaneous anaphylaxis (ACA) was induced. Spleens were collected 24 h after the elicitation of CHS and mRNA expressions of interferon (IFN)-γ, interleukin (IL)-4, IL-6, IL-10, and IL-18 were measured by quantitative RT-PCR. Alcohol-containing diet exaggerated spontaneous dermatitis in conventional NC/Nga mice and contact hypersensitivity in BALB/c mice. Ethanol administered by gavage for 5 days enhanced contact hypersensitivity in BALB/c mice. Ethanol administration with gavage also enhanced ACA of BALB/c mice. Ethanol did not affect mRNA expression of IFN-γ and IL-4, but did enhance IL-6, IL-10, and IL-18 mRNA expression. Histological evaluation revealed an absence of hepatic steatosis in mice administered ethanol by gavage for 5 days. In ethanol-administered mice, inflamed areas presented as lesions or a local extreme accumulation of mononuclear cells in the epidermis. These findings suggest that ethanol enhances the expression of inflammatory cytokines independently from T helper (Th)1/Th2 cytokine phenotypes, causing abnormalities in the epidermis resulting in exacerbated allergic reactivity.


Assuntos
Dermatite Atópica/induzido quimicamente , Dermatite de Contato/etiologia , Etanol/toxicidade , Anafilaxia/imunologia , Animais , Dieta , Feminino , Interferon gama , Interleucina-10 , Interleucina-4 , Interleucina-6 , Camundongos Endogâmicos BALB C , Anafilaxia Cutânea Passiva/imunologia
13.
Biol Pharm Bull ; 36(12): 1969-74, 2013.
Artigo em Inglês | MEDLINE | ID: mdl-24292056

RESUMO

To clarify the relationship between selenium supplementation and type I allergic reaction, we investigated the effect of seleno-L-methionine (SeMet) supplementation on the active cutaneous anaphylaxis (ACA) reaction and cytokine production in splenocytes. Female BALB/c mice were sensitized by intraperitoneal injection of ovalbumin (OVA), and SeMet was administered orally for 2 weeks followed by a challenge with OVA to induce an ACA reaction. SeMet supplementation suppressed the ACA reaction in a dose-dependent manner. Plasma OVA-specific immunoglobulin E (IgE) level was strongly inhibited in SeMet-supplemented mice compared with control mice. The mRNA expression levels of the T helper 2 (Th2) cytokines interleukin (IL)-4 and IL-13 in the spleen of SeMet-supplemented mice were lower than those in control mice. The mRNA expression level of a Th1 cytokine, interferon (IFN)-γ, in the spleen of SeMet-supplemented mice was higher than that in control mice. Splenocytes restimulated with OVA in vitro from SeMet-supplemented mice produced lower amounts of IL-4 and IL-13 than those of control mice and higher amounts of IFN-γ than those from the control mice. These results suggest that oral SeMet supplementation suppresses OVA-induced ACA reaction by lowered Th2 cytokine production and augmenting Th1 cytokine production.


Assuntos
Anafilaxia/tratamento farmacológico , Hipersensibilidade/tratamento farmacológico , Selenometionina/uso terapêutico , Anafilaxia/metabolismo , Animais , Citocinas/genética , Citocinas/metabolismo , Modelos Animais de Doenças , Feminino , Hipersensibilidade/metabolismo , Imunoglobulina E/sangue , Fígado/metabolismo , Camundongos , Camundongos Endogâmicos BALB C , Ovalbumina/imunologia , RNA Mensageiro/metabolismo , Selenometionina/sangue , Selenometionina/farmacocinética , Testes Cutâneos , Baço/citologia , Baço/metabolismo
14.
Biomed Res ; 33(4): 201-10, 2012.
Artigo em Inglês | MEDLINE | ID: mdl-22975630

RESUMO

The purpose of this study was to clarify the cell growth inhibitory mechanism of human breast cancer cells caused by selenium (Se) compounds. In the presence of 17ß-estradiol (E(2)) at physiological concentrations, growth of estrogen receptor α (ERα)-positive T47D cells was markedly inhibited by 1 × 10(-6) mol/L methylseleninic acid (MSA) with no Se related toxicity.Under conditions where cell growth was inhibited, MSA decreased ERα mRNA levels and subsequent protein levels; further decreasing expression of estrogen-responsive finger protein (Efp) which is a target gene product of ERα and promotes G2/M progression of the cell cycle. Therefore, the decline in Efp expression is presumed to be involved in G2 arrest. Coincidentally, the antioxidative thioredoxin/ thioredoxin reductase (Trx/TrxR) system in cells was enhanced by the synergistic action of E(2) and MSA. It has been reported that ROS-induced oxidative stress enhanced ERα expression. E(2) increased production of intracellular ROS in T47D cells. Meanwhile, MSA significantly decreased E(2)-induced ROS accumulation. From these results, activation of the Trx/TrxR system induced by the coexistence of MSA and E(2) suppresses oxidative stress and decreases expression of ERα, and finally induces the growth arrest of T47D cells through disruption of ERα signaling.


Assuntos
Antioxidantes/metabolismo , Neoplasias da Mama/patologia , Estradiol/efeitos adversos , Compostos Organosselênicos/farmacologia , Tiorredoxina Dissulfeto Redutase/metabolismo , Tiorredoxinas/metabolismo , Antineoplásicos/farmacologia , Neoplasias da Mama/enzimologia , Linhagem Celular Tumoral , Proliferação de Células , Sinergismo Farmacológico , Ativação Enzimática , Receptor alfa de Estrogênio/genética , Receptor alfa de Estrogênio/metabolismo , Feminino , Pontos de Checagem da Fase G2 do Ciclo Celular , Regulação Neoplásica da Expressão Gênica , Glutationa Peroxidase/genética , Glutationa Peroxidase/metabolismo , Humanos , Estresse Oxidativo , RNA Mensageiro/genética , RNA Mensageiro/metabolismo , Espécies Reativas de Oxigênio/metabolismo , Transdução de Sinais , Tiorredoxinas/genética , Fatores de Transcrição/genética , Fatores de Transcrição/metabolismo , Proteínas com Motivo Tripartido , Ubiquitina-Proteína Ligases/genética , Ubiquitina-Proteína Ligases/metabolismo , Glutationa Peroxidase GPX1
15.
Biomed Res ; 33(1): 63-6, 2012 Feb.
Artigo em Inglês | MEDLINE | ID: mdl-22361889

RESUMO

Blood glucose and plasma insulin levels between C57BL/6J and ICR strain mice with nicotinamide (NA) and streptozotocin (STZ)-induced diabetes were compared to establish a suitable strain of the experimental diabetic mouse model. The mice were intraperitoneally treated twice with STZ (100 mg/kg) 15 min after injection of NA (120 mg/kg) at a 1-day interval, and non-fasting blood glucose level was then weekly monitored for 5 weeks. The blood glucose level in ICR mice gradually increased and was about 2-times higher than that in C57BL/6J mice at the end of the observation. The plasma insulin level in ICR mice was comparatively low, compared with that in C57BL/6J mice. ICR mice were also markedly glucose-intolerant when oral glucose tolerance test was performed. These results indicate that ICR strain is more sensitive than C57BL/6J strain as a mouse model with NA/STZ-induced mild diabetes.


Assuntos
Diabetes Mellitus Experimental/sangue , Intolerância à Glucose/sangue , Camundongos Endogâmicos C57BL , Camundongos Endogâmicos ICR , Animais , Glicemia , Modelos Animais de Doenças , Teste de Tolerância a Glucose , Insulina/sangue , Masculino , Camundongos , Niacinamida
16.
J Trace Elem Med Biol ; 22(1): 9-16, 2008.
Artigo em Inglês | MEDLINE | ID: mdl-18319135

RESUMO

Although selenium is thought to be essential for various immune responses, the excess supplementation may have an adverse effect on certain immunological functions. The present study was designed to determine the effective chemical forms of selenium and their optimal levels on T-cell mitogenesis with splenic cells from mice given a selenium-deficient diet for 8 weeks to avoid effects of cellular selenium sources. Although selenium in tissues, except for spleen and thymus, was almost depleted by feeding selenium-deficient diet, the lymphoid organs still contained low levels of selenium. Both activities of cellular glutathione peroxidase (cGPx) and thioredoxin reductase (TR) in liver and splenic cells showed a tendency to decrease by selenium deficiency. However, splenic cells were tolerant against decrease of the selenoenzyme activities, and TR was also more tolerant than cGPx. T-cell proliferation of the selenium-insufficient splenic cells induced by concanavalin A was increased by addition of Na2SeO3, Na2SeO4, Na2Se, seleno-DL-cystine, seleno-L-methionine and selenocystamine. Their promoting action was observed at levels lower than 0.1 micromol/L and was completely suppressed at the highest concentration (1 micromol/L), except for selenocystamine. Na2SeO3 was one of the efficient selenocompounds for the mitogenesis, which was concomitant with the significant induction of cGPx and TR. However, recovery of cGPx activity in the selenium-insufficient cells by supplementary Na2SeO3 was only partial,while TR activity was readily recovered from selenium deficiency. These results therefore indicate that only low levels of selenium is essential for T-cell mitogenesis even in selenium-insufficient splenic cells, and TR, which is readily recovered by Na2SeO3, may be the critical enzyme.


Assuntos
Compostos Organosselênicos/farmacologia , Selenito de Sódio/farmacologia , Linfócitos T/efeitos dos fármacos , Animais , Glutationa Peroxidase/metabolismo , Ativação Linfocitária/efeitos dos fármacos , Masculino , Camundongos , Camundongos Endogâmicos ICR , Compostos Organosselênicos/administração & dosagem , Compostos Organosselênicos/metabolismo , Selenito de Sódio/administração & dosagem , Selenito de Sódio/metabolismo , Baço/metabolismo , Linfócitos T/imunologia , Tiorredoxina Dissulfeto Redutase/metabolismo
17.
Biol Trace Elem Res ; 109(2): 155-71, 2006 Feb.
Artigo em Inglês | MEDLINE | ID: mdl-16444005

RESUMO

We earlier found that seleno-l-methionine (L-SeMet) as a food source of selenium (Se) is directly converted to methylselenol (CH3SeH), alpha-ketobutyrate, and ammonia by the mouse hepatic cystathionine gamma-lyase. The purpose of this study was to clarify the biological role of cystathionine gamma-lyase in Se detoxification and cytosolic glutathione peroxidase (cGPx) biosynthesis because another metabolic pathway to CH3SeH via seleno-l-cystathionine and seleno-l-cysteine (l-SeCyH) from l-SeMet has been shown by several enzymatic reactions. When mice were treated with either toxic doses of l-SeMet or a Se-deficient diet, the cystathionine gamma-lyase activity for l-SeMet was invariable, suggesting that this enzyme was effective in both detoxification and biotransformation of Se. Concerning Se biotransformation into cGPx, production of H2Se as the possible precursor was not observed by the in vitro reaction of the liver cytosol with CH3SeH. When l-SeMet was administered at the nutritional dose to mice fed a Se-deficient diet, levels of both cGPx mRNA and cGPx protein were significantly restored. This recovery was not comparatively suppressed by coadministration of periodate-oxidized adenosine, an inhibitor of S-adenosylhomocysteinase, where the conversion of l-SeMet to l-SeCyH is inhibited. However, the recovery was strongly suppressed when propargylglycine, an inhibitor of cystathionine gamma-lyase that catalyzes the alpha,gamma-elimination reaction of both l-SeMet and seleno-l-cystathionine, was treated. These results suggest that cystathionine gamma-lyase is a notable enzyme in SeMet metabolism and that CH3SeH produced by the enzymatic reaction is utilized for cGPx biosynthesis.


Assuntos
Cistationina gama-Liase/metabolismo , Citosol/enzimologia , Glutationa Peroxidase/biossíntese , Fígado/metabolismo , Selenometionina/farmacocinética , Adenosina/análogos & derivados , Adenosina/farmacologia , Alcinos/farmacologia , Análise de Variância , Animais , Cistationina gama-Liase/antagonistas & inibidores , Glutationa Peroxidase/genética , Glicina/análogos & derivados , Glicina/farmacologia , Inativação Metabólica , Fígado/química , Masculino , Metanol/análogos & derivados , Metanol/metabolismo , Camundongos , Camundongos Endogâmicos ICR , Compostos Organosselênicos/metabolismo , RNA Mensageiro/análise , Selênio/deficiência
18.
Biol Trace Elem Res ; 108(1-3): 245-57, 2005.
Artigo em Inglês | MEDLINE | ID: mdl-16327076

RESUMO

The purpose of this study was to identify the seleno-L-methionine (L-SeMet) alpha,gamma-elimination enzyme that catalyzes L-SeMet to generate methylselenol (CH3SeH), a notable intermediate for the metabolism of selenium compounds, in mammalian tissues. The enzyme purified from ICR mouse liver was separated by one-dimensional gel electrophoresis, and the specific band was subjected to in-gel trypsin digestion followed by matrix-assisted laser desorption/ionization-time-of-flight mass spectrometric analysis. In the peptide mass fingerprinting search, the mass numbers of 14 peptides produced by tryptic digestion of the enzyme were consistent with the theoretical mass numbers calculated from the amino acid sequence of murine cystathionine gamma-lyase (E.C. 4.4.1.1). The peptide sequence tags search was also performed to obtain the amino acid sequence data of five tryptic peptides. These peptides were significantly identical to the partial amino acid sequences of cystathionine gamma-lyase. This enzyme was clearly shown to catalyze the alpha,gamma-elimination reaction of L-cystathionine by the enzymological research. The Km value for the catalysis of L-cystathionine was 0.81 mM and Vmax was 0.0013 unit/mg protein. These results suggested that cystathionine gamma-lyase catalyzes L-SeMet to generate CH3SeH by its alpha,gamma-elimination reaction.


Assuntos
Liases de Carbono-Enxofre/química , Cistationina gama-Liase/química , Metanol/análogos & derivados , Compostos Organosselênicos/química , Selenometionina/química , Sequência de Aminoácidos , Animais , Liases de Carbono-Enxofre/metabolismo , Catálise , Cromatografia , Cistationina gama-Liase/metabolismo , Cinética , Fígado/enzimologia , Fígado/metabolismo , Metanol/química , Metanol/metabolismo , Camundongos , Modelos Biológicos , Dados de Sequência Molecular , Compostos Organosselênicos/metabolismo , Espectrometria de Massas por Ionização e Dessorção a Laser Assistida por Matriz
19.
Biol Trace Elem Res ; 106(1): 77-94, 2005 Jul.
Artigo em Inglês | MEDLINE | ID: mdl-16037612

RESUMO

The objective of this study was to purify and characterize a mouse hepatic enzyme that directly generates CH3SeH from seleno-l-methionine (l-SeMet) by the alpha,gamma-elimination reaction. The l-SeMet alpha,gamma-elimination enzyme was ubiquitous in tissues from ICR mice and the activity was relatively high in the large intestine, brain, and muscle, as well as the liver. Aging and sex of the mice did not have any significant influence on the activity in the liver. The enzyme was purified from the mouse liver by ammonium sulfate precipitation and four kinds of column chromatography. These procedures yielded a homogeneous enzyme, which was purified approx 1000-fold relative to mouse liver extract. Overall recovery was approx 8%. The purified enzyme had a molecular mass of approx 160 kDa with four identical subunits. The Km value of the enzyme for the catalysis of l-SeMet was 15.5 mM, and the Vmax was 0.29 units/mg protein. Pyridoxal 5'-phosphate (pyridoxal-P) was required as a cofactor because the holoenzyme could be resolved to the apoenzyme by incubation with hydroxylamine and reconstituted by addition of pyridoxal-P. The enzyme showed the optimum activity at around pH 8.0 and the highest activity at 50 degrees C; it catalyzed the alpha,gamma-elimination reactions of several analogs such as d,l-homocysteine and l-homoserine in addition to l-SeMet. This enzyme also catalyzed the alpha,beta-elimination reaction of Se-methylseleno-l-cysteine. However, l-methionine was inert. Therefore, the purified enzyme was different from the bacterial l-methionine gamma-lyase that metabolizes l-SeMet to CH3SeH, in terms of the substrate specificity. These results were the first identification of a mammalian enzyme that specifically catalyzes the alpha,gamma-elimination reaction of l-SeMet and immediately converts it to CH3SeH, an important metabolite of Se.


Assuntos
Liases de Carbono-Enxofre/química , Liases de Carbono-Enxofre/isolamento & purificação , Fígado/enzimologia , Metanol/análogos & derivados , Compostos Organosselênicos/química , Selenometionina/química , Envelhecimento , Sulfato de Amônio/farmacologia , Animais , Encéfalo/metabolismo , Catálise , Cromatografia , Feminino , Homocisteína/química , Homosserina/química , Humanos , Intestino Grosso/metabolismo , Cinética , Fígado/metabolismo , Masculino , Metanol/química , Metionina/farmacologia , Camundongos , Camundongos Endogâmicos ICR , Músculos/metabolismo , Selênio/química , Especificidade por Substrato , Temperatura
SELEÇÃO DE REFERÊNCIAS
DETALHE DA PESQUISA